Computational Opioid Prescribing: A Novel Application of Clinical Pharmacokinetics

REFERENCES

• Bonham V. Race, ethnicity, and pain treatment: striving to understand the causes and solutions to the disparities in pain treatment. J Law Med Ethics. 2001;29:52–68.
   PubMed Web of Science ®Google Scholar
• Furrow B. Pain management and provider liability: no more excuses. J Law Med Ethics. 2001;29:28–51.
   PubMedGoogle Scholar
• Hoffman D, Tarzian A. The girl who cried pain: a bias against women in the treatment of pain. J Law Med Ethics. 2001;29:13–27.
   PubMed Web of Science ®Google Scholar
• Johnson S. Relieving unnessary, treatable pain for the sake of human diginity. J Law Med Ethics. 2001;29:11–12.
   PubMedGoogle Scholar
• Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19:1985–1991.
   PubMed Web of Science ®Google Scholar
• Drayer R, Henderson J, Reidenberg M. Barriers to better pain control in hospitalized patients. J Pain Symptom Manag 1999;17:434–440.
   PubMed Web of Science ®Google Scholar
• Glajcben M. Chronic pain: treatment barriers and strategies for clinical practice. JABFP. 2001;14:211–218.
   Google Scholar
• Apfelbaum J, Chen C, Mehta S, Gan T. Postoperative pain experience: results from a National survey suggest postoperative pain continues to be undermanages. Anesth Analg. 2003;97:534–540.
   PubMed Web of Science ®Google Scholar
• Richard J, Reidenberg M. The risk of disciplinary action by State Medical Boards against physicians prescribing opioids. J Pain Symptom Manag. 2005;29:206–212.
   PubMed Web of Science ®Google Scholar
• Upton R, Semple T, Mcintyre P. Pharmacokinetic optimization of opioid treatment in acute pain therapy. Clin Pharmacokinet. 1997;33:225–244.
   Google Scholar
• LinaresO. Pharmacokinetics-based opioid prescribing: case report. Pain Pract. 2010;20:18–21.
   Google Scholar
• Mather L. Opioid pharmacokinetics in relation to their effects. Anaesth Intensive Care. 1987;15:15–22.
   PubMed Web of Science ®Google Scholar
• Shafer S, Varvel J. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 1991;74:55–63.
   Google Scholar
• Maitre P. Opioid pharmacokinetics: relationship to response. Curr Opin Anaesthesiol. 1992;5:549–554.
   Google Scholar
• Gourlay G, Willis R, Lamberty J. A double-blind comparison of the efficacy of methadone and morphine in postoperative pain control. Anesthesiology. 1986;64:322–327.
   PubMed Web of Science ®Google Scholar
• Ette E, Williams P, Lane J. Population pharmacokinetics III: design, analysis, and application of population pharmacokinetics. Ann Pharmacother. 2004;38:2136–2144.
   PubMed Web of Science ®Google Scholar
• Nehvar R. Estimation of pharmacokinetic parameters based on the patient-adjusted population data. Am J Pharmaceut Educ. 2006;70:1–8.
   PubMedGoogle Scholar
• Karch S. Pharmacokinetics and Pharmacodynamics of Abused Drugs. Boca Raton, FL: CRC Press; 2007.
   Google Scholar
• Karch S. Drug Abuse Handbook. Boca Raton, FL: CRC Press; 2007.
   Google Scholar
• Karch S. Karch's Pathology of Drug Abuse. 4th ed. Boca Raton, FL: CRC Press; 2008.
   Google Scholar
• Baselt R. Disposition of Toxic Drugs and Chemicals in Man. 8th ed. Foster City, CA: Biomedical Publications; 2009.
   Google Scholar
• Jacob H. Using Published Data: Errors and Remedies. Newbury Park, CA: Sage; 1984.
   Google Scholar
• Wastney M, Patterson B, Linares O, Greif P, Boston R. Investigating Biological Systems Using Modeling: Strategies and Software. San Diego, CA: Academic Press; 1999.
   Google Scholar
• Efron B. Bootstrap methods: Another look at the jacknife. Ann Stat. 1979;7:1–26.
   Web of Science ®Google Scholar
• Efron B. Second thoughts on the bootstrap. Stat Sci. 2003;18:135–140.
   Web of Science ®Google Scholar
• Yafune A, Ishiguro M. Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. I: a use of bootstrap standard error. Stat Med. 1999;18:581– 599.
   PubMed Web of Science ®Google Scholar
• Yafune A, Ishiguro M. Bootstrap approach for constructing confidence intervals for population pharmacokinetic parameters. II: a bootstrap modification of standard two-stage (STS) method for phase I trial. Stat Med. 1999;18:601–612.
   PubMedGoogle Scholar
• Perlin E, Taylor R, Peck C. Clinical pharmacokinetics: a simplified approach, part 1. J Natl Med Assoc. 1985;77:475–482.
   PubMedGoogle Scholar
• Perlin E, Varvel J, Peck C. Clinical pharmacokinetics: a simplified approach, part 2. J Natl Med Assoc. 1986;78: 835–842.
   PubMedGoogle Scholar
• Dvorchik B, Vesell E. Significance of error associated with use of the one-compartment formula to calculate clearance of thirty-eight drugs. Clin Pharmacol Ther. 1978;23:617–623.
   PubMed Web of Science ®Google Scholar
• Mehvar R. Estimation of pharmacokinetic parameters based on patient-adjusted population data. Am J Pharmaceut Educ. 2006;70:1–8.
   PubMedGoogle Scholar
• Ritschel W, Kearns G. Handbook of Basic Pharmacokinetics. 7th ed. Washington, DC: American Pharmacists Association; 2009.
   Google Scholar
• Schoenwald R. Pharmacokinetic Principles of Dosing Adjustment. Boca Raton, FL: CRC Press; 2001.
   Google Scholar
• Armstrong S, Cozza K. Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality. Psychosomatics. 2003;44:515–520.
   PubMed Web of Science ®Google Scholar
• Mehvar R. Pharmacokinetic-based design and modification of dosage regimens. Am J Pharmaceut Educ. 1998;62:189–195.
   Google Scholar
• Ogden C, Fryar C, Carroll M, Flegal K. Mean Body Weight, Height, and Body Mass Index in the United States 1960–2002. Advanced Data From Vital and Health Statistics; No. 347. Hyattsville, MD: National Center for Health Statistics; 2004.
   Google Scholar
• Sawe J. Morphine kinetics in cancer patients. Clin Pharm Ther. 1981;30:629–635.
   PubMed Web of Science ®Google Scholar
• Arnold D, Grics H, Krewski D. Handbook of in Vivo Toxicity Testing. San Diego, CA: Academic Press; 1990.
   Google Scholar
• Hacker M, Bachmann K, Meser W. Pharmacology: Principles and Practice. Burlington, MA: Academic Press; 2009.
   Google Scholar
• Jung B, Reidenberg M. Interpretation of opioid levels: comparison of levels during chronic pain therapy to levels from forensic autopsies. Clin Pharmacol Therapeut. 2005;77:324–334.
   PubMed Web of Science ®Google Scholar
• Meier B. OxyContin prescribers face charges in fatal overdoses. The New York Times. January 19, 2002, 2002:14.
   Google Scholar
• Flannery J II. Pain in America—And How Our Government Makes it Worse. Ithaca, NY: Ithaca Manor Press; 2006.
   Google Scholar
• Spiehler V. Computer-assisted interpretation in forensic toxicology: morphine-involved deaths. J Forensic Sci. 1989;34:1104–1115.
   PubMedGoogle Scholar
• Paulozzi L, Ryan G. Opioid analgesics and rates of fatal drug poisonong in the United States. Am J Prev Med. 2006;31:506–511.
   PubMed Web of Science ®Google Scholar
• Unites States v. Hurwitz, 459 F.3d 463 (4th Cir. 2006). 2006.
   Google Scholar
• Schulz M, Schimoldt A. Therapeutic and toxic blood concentration of more than 800 drugs and xenobiotics. Pharmazie. 2003;58:447–474.
   PubMed Web of Science ®Google Scholar
• Baumann P, Hiemke C, Ulrich S, Eckerman G, Gaertner I, Gerlach M, The AGNP-TDM Expert Group Consensus Guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry. 2004;37:243–265.
   PubMed Web of Science ®Google Scholar
• Peck C, Conner D, Murphy M. Bedside Clinical Pharmacokinetics: Simple Techniques for Individualizing Drug Therapy. Vancouver, WA: Applied Therapeutics; 1991.
   Google Scholar
• Efron B, Tibshirani R. Bootstrap measures for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1:54–57.
   Google Scholar
• Efron B. Better bootstrap confidence intervals (with discussion). J Am Stat Assoc. 1987;82:171–200.
   Web of Science ®Google Scholar
• Efron B, Tibshirani R. An Introduction to the Bootstrap. New York: Chapman and Hall; 1986.
   Google Scholar